Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells
暂无分享,去创建一个
K. Mills | B. Mahon | M. Ryan | F. Griffin
[1] K. Mills,et al. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. , 1997, Developments in biological standardization.
[2] K. Mills,et al. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0 , 1996, Immunology.
[3] H. Hallander,et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.
[4] D Greco,et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. , 1996, The New England journal of medicine.
[5] M. Miller,et al. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. , 1996, Journal of immunology.
[6] A. Abbas,et al. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. , 1996, Journal of immunology.
[7] J. Orange,et al. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. , 1996, Journal of immunology.
[8] F. Finkelman,et al. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. , 1996, Journal of immunology.
[9] M. Miller,et al. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. , 1995, Journal of immunology.
[10] B. Haagmans,et al. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice. , 1995, Journal of immunology.
[11] J. Flynn,et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.
[12] C. Cheers,et al. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection , 1995, Infection and immunity.
[13] A. Nomoto,et al. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor , 1995, The Journal of experimental medicine.
[14] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[15] K. Mills,et al. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. , 1995, Vaccine.
[16] G. Trinchieri,et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. , 1994, Science.
[17] C. Hunter,et al. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.
[18] K. Murphy,et al. Role of cytokines in determining T-lymphocyte function. , 1994, Current opinion in immunology.
[19] A. Sher,et al. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology , 1994, The Journal of experimental medicine.
[20] A. Abbas,et al. Effects of IL-12 on helper T cell-dependent immune responses in vivo. , 1994, Journal of immunology.
[21] E. Unanue,et al. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. , 1994, Journal of immunology.
[22] F. Finkelman,et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. , 1994, Journal of immunology.
[23] A. Sher,et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Mills,et al. Cellular immunity in pertussis. , 1993, Journal of medical microbiology.
[25] K. Mills,et al. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity , 1993, Infection and immunity.
[26] A. Sher,et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[28] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[29] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[30] K. Mills,et al. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model , 1993, Infection and immunity.
[31] K. Hasløv,et al. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis , 1992, Infection and immunity.
[32] E. Akporiaye,et al. Uptake and intracellular survival of Bordetella pertussis in human macrophages , 1992, Infection and immunity.
[33] L. Nencioni,et al. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis , 1991, Infection and immunity.
[34] C. Cabellos,et al. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization , 1991, The Journal of experimental medicine.
[35] T. Gajewski,et al. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. , 1991, Journal of immunology.
[36] R. Sherburne,et al. Invasion of HeLa 229 cells by virulent Bordetella pertussis , 1989, Infection and immunity.
[37] B. Furman,et al. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice. , 1989, Vaccine.
[38] R. Coffman,et al. Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.
[39] J. Cherry,et al. Report of the Task Force on Pertussis and Pertussis Immunization—1988 , 1988, Pediatrics.
[40] R. Bannatyne,et al. Protective effectiveness of an endotoxin-depleted pertussis vaccine. , 1987, Vaccine.
[41] L. Irons,et al. Pertussis vaccine: present status and future prospects. , 1985, Vaccine.
[42] H. Sato,et al. Aerosol infection of mice with Bordetella pertussis , 1980, Infection and immunity.